Barinthus Biotherapeutics plc - American Depositary Shares — Cash Flow (NASDAQ:BRNS)

Financials

Cash from operating activities -32.58 M-14.43 M-50.92 M-28.94 M-47.98 M -36.44 M Cash from investing activities -12.91 M-5.75 M-5.41 M-892 K416 K 476 K Cash from financing activities 222.74 M325 K1.87 M2.16 M2 000 0 Free cash flow -32.58 M-14.43 M-50.92 M-28.94 M-47.98 M -36.44 M

News

BRNS

Financials

News

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Barinthus Bio reports positive initial data from celiac therapy trial

Barinthus Biotherapeutics stock rating reiterated at Buy by H.C. Wainwright

Barinthus Bio and Clywedog to merge in all-stock deal

Barinthus Biotherapeutics’ CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025